Vestmark Advisory Solutions’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $529K | Sell |
1,780
-31
| -2% | -$10K | 0.01% | 1050 |
|
|
2025
Q4 | $550K | Sell |
1,811
-43
| -2% | -$14.1K | 0.01% | 970 |
|
|
2025
Q3 | $632K | Buy |
1,854
+15
| +0.8% | +$4.55K | 0.01% | 642 |
|
|
2025
Q2 | $445K | Sell |
1,839
-1,499
| -45% | -$368K | 0.01% | 639 |
|
|
2025
Q1 | $909K | Buy |
3,338
+1,686
| +102% | +$394K | 0.02% | 409 |
|
|
2024
Q4 | $305K | Buy |
1,652
+4
| +0.2% | +$817 | 0.01% | 489 |
|
|
2024
Q3 | $370K | Sell |
1,648
-1,357
| -45% | -$244K | 0.01% | 419 |
|
|
2024
Q2 | $429K | Sell |
3,005
-84
| -3% | -$12.9K | 0.02% | 418 |
|
|
2024
Q1 | $483K | Buy |
3,089
+1,488
| +93% | +$240K | 0.02% | 393 |
|
|
2023
Q4 | $289K | Buy |
1,601
+139
| +10% | +$25.1K | 0.01% | 423 |
|
|
2023
Q3 | $263K | Sell |
1,462
-1,840
| -56% | -$364K | 0.02% | 357 |
|
|
2023
Q2 | $589K | Sell |
3,302
-61
| -2% | -$14K | 0.02% | 562 |
|
|
2023
Q1 | $725K | Sell |
3,363
-45
| -1% | -$10.8K | 0.03% | 511 |
|
|
2022
Q4 | $750K | Buy |
3,408
+1,350
| +66% | +$248K | 0.04% | 489 |
|
|
2022
Q3 | $277K | Sell |
2,058
-976
| -32% | -$168K | 0.02% | 689 |
|
|
2022
Q2 | $491K | Buy |
3,034
+1,335
| +79% | +$209K | 0.03% | 542 |
|
|
2022
Q1 | $320K | Buy |
1,699
+362
| +27% | +$77K | 0.02% | 700 |
|
|
2021
Q4 | $362K | Sell |
1,337
-36
| -3% | -$12.2K | 0.02% | 646 |
|
|
2021
Q3 | $498K | Buy |
1,373
+82
| +6% | +$26.8K | 0.03% | 491 |
|
|
2021
Q2 | $443K | Buy |
1,291
+98
| +8% | +$32.5K | 0.03% | 512 |
|
|
2021
Q1 | $415K | Buy |
1,193
+412
| +53% | +$136K | 0.04% | 498 |
|
|
2020
Q4 | $202K | Buy |
781
+70
| +10% | +$19.3K | 0.02% | 583 |
|
|
2020
Q3 | $204K | Buy |
+711
| New | +$167K | 0.03% | 525 |
|
Other funds holding ONC
BBA
HA
